Log In
Print
BCIQ
Print
Print this Print this
 

MBX-701

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionNon-nucleoside HCV NS5B inhibitor
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationHepatitis C virus (HCV)
Partner

Microbiotix Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today